Nelson Advisors Deconstructs the Oracle Health - Oracle Cerner Divestiture

In 2026, Oracle Corporation faces a significant liquidity challenge as it prioritises massive investments in artificial intelligence infrastructure, leading to speculation regarding the sale of its Oracle Health unit.

This source evaluates the strategic and financial landscape surrounding the potential divestiture of the Cerner asset, which originally cost the company $28.3 billion. Major technology firms like Microsoft, Amazon, and Google are identified as logical suitors, though they face substantial antitrust hurdles and concerns over platform neutrality.

Additionally, private equity consortiums are presented as a high-probability alternative for a complex carve-out that would allow Oracle to retain its hosting revenue. The analysis also considers the impact of federal government oversight and the technical difficulties of decoupling the software from Oracle's cloud. Ultimately, the text suggests that while a full sale to Big Tech is possible, a structured deal with private investors is the most likely outcome to stabilize the platform's future.

To discuss how Nelson Advisors can help your HealthTech, MedTech, Health AI or Digital Health company, please email [email protected]